Cognis Prevastein "Bone Health" Claim Cleared By FDA
This article was originally published in The Tan Sheet
Executive Summary
Cognis Nutrition & Health is preparing to introduce its Prevastein soy isoflavone ingredient for post-menopausal "bone health" following resolution with FDA of potential structure/function claim language.
You may also be interested in...
Bioenergy Nutrients Respiratory Claims Cited In FDA Courtesy Letter
Three of five products marketed by Amrion's Bioenergy Nutrients division were cited in a May 22 FDA "courtesy" letter for making structure/function claims referring to "respiratory disorders."
Cognis Nutrition and Health
Henkel Nutrition and Health Group, a division of Henkel Corp., is renamed Cognis Nutrition and Health as of Jan. 1, 2000. The company adopted the new name and logo under new VP Michael Sundos, PhD, with the hopes of reworking its image as a customer-oriented manufacturer; Cognis comes from the Latin root "cognoscere," meaning to realize or notice. The division is now concentrating on marketing products with lutein, including its Xangold brand and Whitehall Robins' Centrum and Centrum Silver, for which Cognis supplies lutein esters. The division also plans to release Prevastein, a product containing soy isoflavones, soon in collaboration with Central Soya
P&G Brings Price-Fixing Suit Against Vitamin Manufacturers
Procter & Gamble filed suit against various vitamin manufacturers in Cincinnati, Ohio federal court Sept. 24, becoming the latest bulk vitamin purchaser to seek compensation for alleged price-fixing spanning a decade. Suits by approximately 14 companies and a class action are proceeding against various vitamin makers.